2025-02-01 2026-01-31 false Capium Accounts Production 1.1 08362513 2025-02-01 2026-01-31 08362513 bus:AbridgedAccounts 2025-02-01 2026-01-31 08362513 bus:FRS102 2025-02-01 2026-01-31 08362513 bus:AuditExemptWithAccountantsReport 2025-02-01 2026-01-31 08362513 bus:SmallCompaniesRegimeForAccounts 2025-02-01 2026-01-31 08362513 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 08362513 2025-02-01 2026-01-31 08362513 2026-01-31 08362513 bus:RegisteredOffice 2025-02-01 2026-01-31 08362513 core:WithinOneYear 2026-01-31 08362513 core:AfterOneYear 2026-01-31 08362513 1 2025-02-01 2026-01-31 08362513 bus:Director1 2025-02-01 2026-01-31 08362513 bus:Director1 2026-01-31 08362513 bus:Director1 2024-02-01 2025-01-31 08362513 2024-02-01 08362513 bus:LeadAgentIfApplicable 2025-02-01 2026-01-31 08362513 2024-02-01 2025-01-31 08362513 2025-01-31 08362513 core:WithinOneYear 2025-01-31 08362513 core:AfterOneYear 2025-01-31 08362513 bus:EntityAccountantsOrAuditors 2024-02-01 2025-01-31 08362513 bus:OrdinaryShareClass1 2025-02-01 2026-01-31 08362513 bus:OrdinaryShareClass1 2026-01-31 08362513 bus:OrdinaryShareClass1 2024-02-01 2025-01-31 08362513 bus:OrdinaryShareClass1 2025-01-31 08362513 core:CostValuation core:Non-currentFinancialInstruments 2026-01-31 08362513 core:CostValuation core:Non-currentFinancialInstruments 2025-01-31 08362513 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-01-31 08362513 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 08362513 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 08362513 core:Non-currentFinancialInstruments 2026-01-31 08362513 core:Non-currentFinancialInstruments 2025-01-31 08362513 core:ShareCapital 2026-01-31 08362513 core:ShareCapital 2025-01-31 08362513 core:RetainedEarningsAccumulatedLosses 2026-01-31 08362513 core:RetainedEarningsAccumulatedLosses 2025-01-31 08362513 dpl:Item1 2025-02-01 08362513 dpl:Item1 2026-01-31 08362513 dpl:Item1 2024-02-01 08362513 dpl:Item1 2025-01-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 08362513
DRPLAMEN CARE LTD
Abridged Accounts
Period of accounts Start date: 01 February 2025 End date: 31 January 2026

DrPlamen Care Ltd Contents Page For the year ended 31 January 2026
Accountants' report | 1
Statement of financial position | 2
Notes to the financial statements | 3

DrPlamen Care Ltd Accountants' Report For the year ended 31 January 2026
.................................................... TA Partners 7 Waveney Close London E1W 2JL 29 March 2026 1

DrPlamen Care Ltd Statement of Financial Position As at 31 January 2026
| Notes | 2026 £ |  | 2025 £
--- | --- | --- | --- | ---
Current assets |  |  |
Cash at bank and in hand |  | 348,999 |  | 331,444
Creditors: amount falling due within one year |  | (39,708) |  | (37,478)
Net current assets |  | 309,291 |  | 293,966
Total assets less current liabilities |  | 309,291 |  | 293,966
Net assets |  | 309,291 |  | 293,966
Capital and reserves |  |  |
Called up share capital | 3 | 100 |  | 100
Profit and loss account |  | 309,191 |  | 293,866
Shareholders' funds |  | 309,291 |  | 293,966
For the year ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the director on 29 March 2026 and were signed by:
------------------------------- Plamen Tatishev Director
2

DrPlamen Care Ltd Notes to the Abridged Financial Statements For the year ended 31 January 2026
General Information DrPlamen Care Ltd is a private company, limited by shares, registered in , registration number 08362513, registration address 19 St Marys Park, Louth, LN11 0EF. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Taxation Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Current and deferred tax assets and liabilities are not discounted
2. | Average number of employees Average number of employees during the year was 2 (2025 : 2).
3. | Share Capital
Allotted, called up and fully paid | 2026 £ |  | 2025 £
--- | --- | --- | ---
100 Class A shares of £1.00 each | 100 |  | 100
| 100 |  | 100
3